Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications

被引:26
作者
de Heredia, CD
Moreno, A
Olivé, T
Iglesias, J
Ortega, JJ
机构
[1] Hosp Univ Materno Infantil Vall Hebron, Dept Haematol Oncol, BMT Unit, Barcelona, Spain
[2] Hosp Univ Materno Infantil Vall Hebron, Intens Care Unit, Barcelona, Spain
关键词
bone marrow transplantation; life-threatening complications; intensive care; children;
D O I
10.1038/sj.bmt.1701874
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The role of support measures in the Intensive Care Unit for bone marrow transplant recipients has been controversial. Data from 176 pediatric bone marrow transplants were retrospectively analyzed to ascertain the probability, causes, risk factors and survival for life-threatening complications requiring intensive care. Ninety-two patients underwent allogeneic BMT and 84 autologous BMT between January 1991 and December 1995. Thirty-one ICU admissions were recorded. The most frequent causes mere acute respiratory failure (n = 15, mostly interstitial pneumopathies), septic shock (n = 5) neurological disorders (n = 5) and heart failure (n = 2). The cumulative incidence of an ICU admission at 20 months post-transplant in patients with an allogeneic BMT was 25.7% (CI: 16.4-35.1), compared with 10.8% (CI: 4.2-17.5) in those with an autologous graft (P = 0.04). ICU admission frequency was maximum during the first 2 months post-transplant. All complications in patients with autologous transplants appeared during the first 5 months post-transplant. Among patients with allogeneic grafts, four were later admitted to the ICU, at 7, 9, 12 and 20 months post-transplant, respectively. The main risk factor for ICU admission was acute GVHD grades III-IV. No differences were found between patients with allogeneic transplants with GVHD grades 0-II and those undergoing autologous transplant. In contrast, differences were highly significant between patients undergoing allogeneic transplants with GVHD grades III-IV and those with GVHD grades 0-II, or autologous transplants. No differences were observed between allogeneic and autologous transplants in terms of causes for ICU admission, duration of stay, hours on mechanical ventilation, hours on inotropic drug therapy and numbers of organs failing. Neither were differences found in ICU discharge survival between patients with allogeneic (50%, CI: 29.1-70.9) and autologous (66.7%, CI: 29.9-89.1) transplants. ICU discharge survival in patients admitted for lung disease was 28.6% (CI: 12.1-65.6) but 76.5% (CI: 41.9-87.8) in patients admitted for other causes (P = 0.007). ICU discharge survival in mechanically ventilated patients was 46.2% (CI: 27.0-65.4), significantly lower than nonventilated patients (100%). Three-year survival in all transplanted patients admitted to the ICU was 29.7% (CI: 13.1-45.0) compared with 70.2% (CI: 62.7-77.6) in patients not requiring ICU admission (P < 0.001). Although a complication requiring admission to the ICU is, as confirmed by multivariate analysis, an unfavorable factor in long-term survival of transplanted patients, it must be emphasized that three of every 10 patients admitted to the ICU were alive and well at 3 years. Intensive care support in these patients can be life-saving.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 17 条
[1]   OUTCOME OF RECIPIENTS OF BONE-MARROW TRANSPLANTS WHO REQUIRE INTENSIVE-CARE UNIT SUPPORT [J].
AFESSA, B ;
TEFFERI, A ;
HOAGLAND, HC ;
LETENDRE, L ;
PETERS, SG .
MAYO CLINIC PROCEEDINGS, 1992, 67 (02) :117-122
[2]   LONG-TERM SURVIVAL FROM RESPIRATORY-FAILURE AFTER MARROW TRANSPLANTATION FOR MALIGNANCY [J].
CRAWFORD, SW ;
PETERSEN, FB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03) :510-514
[3]   MECHANICAL VENTILATION AFTER MARROW TRANSPLANTATION - RISK-FACTORS AND CLINICAL OUTCOME [J].
CRAWFORD, SW ;
SCHWARTZ, DA ;
PETERSEN, FB ;
CLARK, JG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :682-687
[4]   EFFICACY OF INTENSIVE-CARE FOR BONE-MARROW TRANSPLANT PATIENTS WITH RESPIRATORY-FAILURE [J].
DENARDO, SJ ;
OYE, RK ;
BELLAMY, PE .
CRITICAL CARE MEDICINE, 1989, 17 (01) :4-6
[5]  
Epner DE, 1996, J INVEST MED, V44, P254
[6]  
FABERLANGENDOEN K, 1993, BONE MARROW TRANSPL, V12, P501
[7]   The outcome of children requiring admission to an intensive care unit following bone marrow transplantation [J].
Hayes, C ;
Lush, RJ ;
Cornish, JM ;
Foot, AM ;
Henderson, T ;
Jenkins, I ;
Murphy, P ;
Oakhill, A ;
Pamphilon, DH ;
Steward, CG ;
Weir, P ;
Wolf, A ;
Marks, DI .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :666-670
[8]  
Hollmig K A, 1997, Eur J Med Res, V2, P62
[9]   Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors [J].
Jackson, SR ;
Tweeddale, MG ;
Barnett, MJ ;
Spinelli, JJ ;
Sutherland, HJ ;
Reece, DE ;
Klingemann, HG ;
Nantel, SH ;
Fung, HC ;
Toze, CL ;
Phillips, GL ;
Shepherd, JD .
BONE MARROW TRANSPLANTATION, 1998, 21 (07) :697-704
[10]  
LLOYDTHOMAS AR, 1986, INTENS CARE MED, V12, P317